Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

COVID 19 and Hemoglobinopathies: Update of the Italian Experience

Irene Motta, MD, Valeria Maria Pinto, MD, Filomena Longo, MD, Federico Bonetti, MD, Elisa De Michele, MD, Alberto Piperno, MD, Lorella Pitrolo, MD, Micol Quaresima, MD, Michela Ribersani, MD, Margherita Migone De Amicis, MD, Manuela Balocco, MD, Barbara Gianesin, PhD, Giovanna Graziadei, MD, Maria Domenica Cappellini, MD, Lucia De Franceschi, MD, Antonio Piga, MD, Gian Luca Forni, MD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-141610

Published: 2020

Journal Articles

Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Comparison of Deferasirox Formulations for Treatment Tailoring

Andrea Piolatto, MS, Carmen Gaglioti, MD, Filomena Longo, MD, Silvia De Francia, PhD, Sarah Allegra, PhD, Paola Berchialla, PhD, Antonio Piga

Blood (2019) 134 (Supplement_1): 3547.

https://doi.org/10.1182/blood-2019-122030

Published: 2019

Journal Articles

Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm

Donatella Baronciani, MD, Maddalena Casale, MD, Lucia De Franceschi, MD, Giovanna Graziadei, MD, Filomena Longo, MD, Raffaella Origa, MD, Valeria Maria Pinto, MD, Paolo Rigano, MD, Monia Marchetti, MD, Antonia Gigante, Emanuele Angelucci, MD, Maria Domenica Cappellini, MD, Achille Iolascon, MD PhD, Antonio Piga, Gian Luca Forni

Blood (2019) 134 (Supplement_1): 972.

https://doi.org/10.1182/blood-2019-128320

Published: 2019

Journal Articles

Liver Iron Measurements with Less Expensive Technology: Comparison of a Room-Temperature Susceptometer with SQUID in 84 Subjects

Alberto Fenzi, PhD, Filomena Longo, MD, Antonio Piga, Daniela Ventura, MD, Andrea Sboarina, PhD, Sankaran Kumar, PhD, William Avrin, PhD

Blood (2018) 132 (Supplement 1): 3628.

https://doi.org/10.1182/blood-2018-99-116955

Published: 2018

Journal Articles

Growth Differentiation Factor 15 (GDF15) and Erythropoietin (EPO) Levels in Beta Talassemia Major Patients.

Ilaria Salussoglia, MD, Gisella Volpe, PhD, Silvia Fracchia, MD, Simona Roggero, MD, Filomena Longo, MD, Antonio Piga, MD

Blood (2008) 112 (11): 1881.

https://doi.org/10.1182/blood.V112.11.1881.1881

Published: 2008

Journal Articles

Quantification by Superconducting Quantum Interference Device (SQUID) of Iron Overload after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Alessandro Busca, MD, Michele Falda, Paola Manzini, Sergio D’antico, Franco Locatelli, Annalisa Chiappella, Stefano D’Ardia, Filomena Longo, MD, Roberto Calabrese, Antonio Piga, MD

Blood (2008) 112 (11): 2134.

https://doi.org/10.1182/blood.V112.11.2134.2134

Published: 2008

Journal Articles

Effect of Iron Chelators on Cardiac Iron Assessed by MR T2* in Thalassemia Major

Renzo Galanello, MD, Antonio Piga, MD, Maria- Eliana Lai, MD, Gianluca Forni, MD, Fabrice Danjou, Filomena Longo, MD, Annalisa Agus, Raffaella Origa

Blood (2008) 112 (11): 3886.

https://doi.org/10.1182/blood.V112.11.3886.3886

Published: 2008

Journal Articles

Liver Fibrosis Assessment by Ultrasound Elastometry in Thalassemic Patients on Long-Term Iron Chelation.

Filomena Longo, MD, Fabio Marletto, MD, Elisa Rivetti, MD, Laura Sacchetti, MD, Antonio Piga, MD

Blood (2006) 108 (11): 1780.

https://doi.org/10.1182/blood.V108.11.1780.1780

Published: 2006

Journal Articles

Comparison of Liver Iron Concentration Measured by the SQUID Biosusceptometers at Hamburg, Torino and Oakland in Patients with Thalassemia and Sickle Cell Disease.

Ellen B. Fung, PhD, RD, Filomena Longo, MD, Roland Fischer, PhD, Rainer Engelhardt, PhD, Zahra Pakbaz, MD, Herbert Optiz, PhD, Robert L. Fagaly, PhD, Hanspeter Nick, PhD, Peter Nielsen, MD, PhD, Elliott Vichinsky, MD, Antonio Piga, MD, Paul Harmatz, MD

Blood (2005) 106 (11): 3721.

https://doi.org/10.1182/blood.V106.11.3721.3721

Published: 2005

Journal Articles

Once-Daily Treatment with the Oral Iron Chelator ICL670 (Exjade®): Results of a Phase II Study in Pediatric Patients with β-Thalassemia Major.

Antonio Piga, MD, Renzo Galanello, MD, Maria Loreta Foschini, MD, Antonella Zappu, MD, Elena Bordone, MD, Filomena Longo, MD, Gian-Luca Forni, MD, Antonella Lavagetto, MD, Yves Bertrand, MD, Henry Maseruka, PhD, Nicola Latham, MSc, Daniele Alberti, MD

Blood (2004) 104 (11): 3614.

https://doi.org/10.1182/blood.V104.11.3614.3614

Published: 2004

NARROW

COVID 19 and Hemoglobinopathies: Update of the Italian Experience

Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Comparison of Deferasirox Formulations for Treatment Tailoring

Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm

Liver Iron Measurements with Less Expensive Technology: Comparison of a Room-Temperature Susceptometer with SQUID in 84 Subjects

Growth Differentiation Factor 15 (GDF15) and Erythropoietin (EPO) Levels in Beta Talassemia Major Patients.

Quantification by Superconducting Quantum Interference Device (SQUID) of Iron Overload after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Effect of Iron Chelators on Cardiac Iron Assessed by MR T2* in Thalassemia Major

Liver Fibrosis Assessment by Ultrasound Elastometry in Thalassemic Patients on Long-Term Iron Chelation.

Comparison of Liver Iron Concentration Measured by the SQUID Biosusceptometers at Hamburg, Torino and Oakland in Patients with Thalassemia and Sickle Cell Disease.

Once-Daily Treatment with the Oral Iron Chelator ICL670 (Exjade®): Results of a Phase II Study in Pediatric Patients with β-Thalassemia Major.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only